Last $31.29 USD
Change Today -0.68 / -2.13%
Volume 304.2K
OFIX On Other Exchanges
As of 8:10 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

orthofix international nv (OFIX) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/2/14 - $36.90
52 Week Low
10/9/13 - $19.35
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

orthofix international nv (OFIX) Related Businessweek News

No Related Businessweek News Found

orthofix international nv (OFIX) Details

Orthofix International N.V., a medical device company, designs, develops, manufactures, markets, and distributes medical devices used principally by musculoskeletal medical specialists for spine and orthopedic applications. The company operates in four segments: BioStim, Biologics, Extremity Fixation, and Spine Fixation. The BioStim segment offers a range of devices for use as adjunctive treatment to enhance fusion success in cervical and lumbar spine fusion, as well as a therapeutic treatment for non-healing fractures outside of the spine. The Biologics segment provides a portfolio of regenerative products that allow physicians to treat a range of spinal and orthopedic conditions under the Trinity Evolution and Trinity Elite names. The Extremity Fixation segment offers orthopedic products used in fracture repair, deformity correction, and bone reconstruction. The Spine Fixation segment provides a range of implant products used in surgical procedures of the spine. The company markets and distributes its products directly to hospitals, doctors, and other healthcare providers in the United States, the United Kingdom, Italy, Germany, Switzerland, Austria, France, Belgium, Brazil, Australia, and Puerto Rico, as well as through independent distributors, sales representatives, and affiliates in other markets. Orthofix International N.V. was founded in 1987 and is headquartered in Curaçao, the Netherlands Antilles.

889 Employees
Last Reported Date: 03/31/14
Founded in 1987

orthofix international nv (OFIX) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $452.8K
President of Global Extremity Fixation
Total Annual Compensation: $437.2K
Chief Strategy Officer
Total Annual Compensation: $460.0K
Chief Administrative Officer, General Counsel...
Total Annual Compensation: $455.0K
Compensation as of Fiscal Year 2013.

orthofix international nv (OFIX) Key Developments

Orthofix International To Request NASDAQ Hearings Panel To Stay NASDAQ Delisting

As previously disclosed, the Orthofix International N.V. has delayed the filing of the 2014 Second Quarter Form 10-Q as a result of certain accounting matters. As a result, the Company is currently out of compliance with NASDAQ Stock Market Listing Rule 5250(c)(1). On August 15, 2014, the Company received a letter from NASDAQ stating that unless the Company requests a hearing before a NASDAQ Listing Qualifications Panel (Hearings Panel) by August 22, 2014, the Company’s common stock will be delisted. Under NASDAQ’s rules and procedures, in general, a company’s request for such a hearing automatically stays any delisting for 15 calendar days from the deadline to request a hearing. The Company will file a hearing request on or prior to August 22, 2014 and request a further stay of delisting. The letter states that the hearing would be expected to occur 30-45 days following the date that the Company submits its hearing request. If the Hearings Panel grants the Company’s request for a further stay (which is discretionary on the part of the Hearings Panel and therefore not assured), any final delisting will be stayed until further Hearings Panel proceedings. The letter states that given the circumstances that prevented the Company from timely filing the 2014 Second Quarter Form 10-Q, the NASDAQ listing staff would not object to the Hearings Panel granting the Company an extended stay of delisting. The Company currently expects to file the 2014 Second Quarter Form 10-Q prior to the end of September 2014.

Orthofix International N.V. announced delayed 10-Q filing

On 08/12/2014, Orthofix International N.V. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Orthofix International N.V. Provides Net Sales Guidance for the Second Quarter Ended June 30, 2014

Orthofix International N.V. provided net sales guidance for the second quarter ended June 30, 2014. For the quarter, the company expects to report net sales of $101.3 million.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OFIX:US $31.29 USD -0.68

OFIX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alphatec Holdings Inc $1.70 USD -0.10
K2M Group Holdings Inc $14.14 USD -0.26
Ossur HF 319.00 0.00
RTI Surgical Inc $5.12 USD -0.01
Thoratec Corp $26.14 USD -0.26
View Industry Companies

Industry Analysis


Industry Average

Valuation OFIX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.4x
Price/Book 1.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORTHOFIX INTERNATIONAL NV, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at